These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28984474)

  • 21. Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.
    Peng R; Zhang PF; Zhang C; Huang XY; Ding YB; Deng B; Bai DS; Xu YP
    Cancer Med; 2018 Mar; 7(3):796-808. PubMed ID: 29446253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver.
    Liu W; Chen JR; Hsu CH; Li YH; Chen YM; Lin CY; Huang SJ; Chang ZK; Chen YC; Lin CH; Gong HY; Lin CC; Kawakami K; Wu JL
    Hepatology; 2012 Dec; 56(6):2268-76. PubMed ID: 22729936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes.
    Meng F; Yamagiwa Y; Ueno Y; Patel T
    J Hepatol; 2006 Jun; 44(6):1055-65. PubMed ID: 16469407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.
    Li Z; Tang M; Ling B; Liu S; Zheng Y; Nie C; Yuan Z; Zhou L; Guo G; Tong A; Wei Y
    J Mol Med (Berl); 2014 Mar; 92(3):291-303. PubMed ID: 24281831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways.
    Duan L; Wu R; Zou Z; Wang H; Ye L; Li H; Yuan S; Li X; Zha H; Sun H; Zhang Y; Chen X; Zhou L
    Int J Oncol; 2014 Mar; 44(3):781-90. PubMed ID: 24378749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle.
    Qiu B; Chen T; Sun R; Liu Z; Zhang X; Li Z; Xu Y; Zhang Z
    EBioMedicine; 2019 Dec; 50():166-177. PubMed ID: 31761616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
    Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
    Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype.
    Ding YB; Deng B; Huang YS; Xiao WM; Wu J; Zhang YQ; Wang YZ; Wu DC; Lu GT; Wu KY
    Dig Dis Sci; 2013 Jun; 58(6):1627-35. PubMed ID: 23306848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways.
    Chen XX; Yin Y; Cheng JW; Huang A; Hu B; Zhang X; Sun YF; Wang J; Wang YP; Ji Y; Qiu SJ; Fan J; Zhou J; Yang XR
    Cell Death Dis; 2018 Oct; 9(10):1036. PubMed ID: 30305612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma.
    Liu L; Wu J; Guo Y; Xie W; Chen B; Zhang Y; Li S; Hua Y; Peng B; Shen S
    Aging (Albany NY); 2018 Dec; 10(12):4120-4140. PubMed ID: 30580327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
    Xu YP; Dong ZN; Zhou YQ; Zhao YJ; Zhao Y; Wang F; Huang XY; Guo CY
    Dig Dis Sci; 2022 Feb; 67(2):559-568. PubMed ID: 33576946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-101 inhibits the migration and invasion of intrahepatic cholangiocarcinoma cells via direct suppression of vascular endothelial growth factor-C.
    Deng G; Teng Y; Huang F; Nie W; Zhu L; Huang W; Xu H
    Mol Med Rep; 2015 Nov; 12(5):7079-85. PubMed ID: 26299768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
    Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma.
    Wang J; Zhang K; Wang J; Wu X; Liu X; Li B; Zhu Y; Yu Y; Cheng Q; Hu Z; Guo C; Hu S; Mu B; Tsai CH; Li J; Smith L; Yang L; Liu Q; Chu P; Chang V; Zhang B; Wu M; Jiang X; Yen Y
    Oncotarget; 2015 Aug; 6(22):18905-20. PubMed ID: 26056085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
    Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
    Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
    Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
    J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.